New hope for patients with devastating immune storm

NCT ID NCT07208058

Summary

This study is testing an experimental drug called plonmarlimab for people with a severe, life-threatening immune system overreaction called HLH or MAS, which is linked to other rheumatic diseases. It is for patients aged 16-80 whose condition did not improve or worsened after high-dose steroid treatment. The main goal is to see if the drug can control the disease and is safe for these patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY RHEUMATIC AND IMMUNOLOGIC DISEASE-ASSOCIATED HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Friendship Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact Email: •••••@•••••

  • Children's Hospital of Fudan University

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

  • Children's Hospital of Zhengzhou University

    NOT_YET_RECRUITING

    Zhengzhou, Henan, China

    Contact

  • Huashan Hospital, Fudan University

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, China

    Contact

  • Peking University People's Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, China

    Contact

  • Renji Hospital, Shanghai Jiao Tong University School of Medicine

    RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

    Contact

  • The First Affiliated Hospital of China Medical University

    NOT_YET_RECRUITING

    Shenyang, Liaoning, China

    Contact

  • The First Affiliated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, China

    Contact

  • The First Affiliated Hospital of Zhengzhou University

    NOT_YET_RECRUITING

    Zhengzhou, Henan, China

    Contact

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, China

    Contact

  • The Second Hospital of Hebei Medical University

    NOT_YET_RECRUITING

    Shijiazhuang, Hebei, China

    Contact

  • Tianjin Medical University General Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, China

    Contact

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    NOT_YET_RECRUITING

    Wuhan, Hubei, China

    Contact

Conditions

Explore the condition pages connected to this study.